查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576952

顱內動脈瘤:市場洞察·競爭環境·市場預測 (～2030年)

Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

顱內動脈瘤市場規模預計將從 2023 年的 11.3 億美元增至 2030 年的 19 億美元，在 2024-2030 年預測期內複合年增長率為 9.10%。

顱內動脈瘤市場正在經歷顯著的市場成長，這主要是由於高血壓等慢性疾病的增加、主要參與者的創新產品開發活動、人口老齡化的擴大以及政府舉措的增加。

顱內動脈瘤市場動態：

根據世界衛生組織 (WHO) 2023 年的數據，全球估計有 12.8 億 30 歲至 79 歲的成年人患有高血壓，並且生活在低收入和中等收入國家。高血壓是顱內動脈瘤的重要危險因素，促使對有效診斷和治療方案的需求不斷增加，從而促使與顱內動脈瘤治療相關的醫療設備和技術市場不斷擴大。

根據世界衛生組織2021年數據，2015年至2050年間，60歲及以上人口數量將翻一番，從12%增至22%，預計2050年將達到21億。此外，到 2030 年，六分之一的人將超過 60 歲。與年齡相關的健康問題（例如可導致顱內動脈瘤的腦血管疾病）日益普遍，需要先進的診斷和治療方案。隨著醫療保健系統投資於血管內治療和技術以有效管理動脈瘤，這些人口變化正在推動市場成長。

根據顱內動脈瘤的產品類型，栓塞彈簧圈預計將在 2023 年佔據很大的收入佔有率。這是因為栓塞彈簧圈被廣泛使用，並且具有多種關鍵特徵，可以增強其實用性和有效性。

栓塞彈簧圈在顱內動脈瘤的微創治療中非常重要，它具有高靈活性和 X 光下可視性等關鍵特性，可確保在動脈瘤內精確放置。這些線圈通常由鉑製成，可膨脹以填充動脈瘤囊，從而誘導血塊形成並降低破裂的風險。有些線圈塗有生物活性或水凝膠材料，以促進動脈瘤內的凝血和癒合。

按地區劃分，北美地區預計將在 2023 年引領市場，並在預測期內表現出類似的地位。除了腦動脈瘤的高發生率之外，包括產品開發和監管審批方面的重大發展、市場中主要參與者的存在以及先進醫療基礎設施的可用性在內的幾個因素預計將在預計區域增長。

本報告提供全球顱內動脈瘤的市場調查，提供市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 顱內動脈瘤市場:簡介

第2章 顱內動脈瘤市場:摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 顱內動脈瘤市場:主要要素分析

  • 推動市場要素
    • 慢性疾病增加
    • 增加產品開發活動
    • 與生活方式相關的疾病增加
    • 人口老化加劇
  • 阻礙市場要素·課題
    • 嚴格的監理審批流程
    • 與顱內動脈瘤治療裝置相關的併發症
  • 市場機會
    • 生物可吸收材料的研究
    • 全球和區域製造商的策略性業務活動

第6章 顱內動脈瘤市場:波特的五力分析

第7章 顱內動脈瘤市場:市場評估

  • 各產品類型
    • 手術夾閉
    • 栓塞線圈
    • 分流器
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 顱內動脈瘤市場:企業·產品簡介

  • Medtronic
  • MicroPort Scientific Corporation.
  • B. Braun Melsungen AG
  • Stryker
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Penumbra, Inc.
  • Balt
  • Wallaby Medical
  • Shape Memory Medical Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Spartan Micro, Inc.
  • Mizuho Medical Co. Ltd
  • Lepu Medical Technology Co., Ltd.
  • Phenox GmbH
  • Peter LAZIC GmbH
  • adeor medical AG
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • KANEKA CORPORATION

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明·諮詢方式

Product Code: DIMDCL0527

Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide

The intracranial aneurysms market was valued at USD 1.13 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 1.90 billion by 2030. The intracranial aneurysms market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as hypertension, innovative product developmental activities by leading companies, expanding geriatric population, and increasing government initiatives that are factors expected to escalate the overall growth of the intracranial aneurysms market during the forecast period from 2024 to 2030.

Intracranial Aneurysms Market Dynamics:

As per data provided by the World Health Organization (WHO) (2023), it stated that an estimated 1.28 billion adults aged between 30 and 79 years worldwide had hypertension, living in low- and middle-income countries. High blood pressure or hypertension is a significant risk factor for intracranial aneurysms, leading to an increased demand for effective diagnostic and treatment options and thus resulting in a larger market for medical devices and technologies related to intracranial aneurysm treatment.

Data from the WHO 2021, stated that between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. Due to the higher prevalence of age-related health issues, including cerebrovascular diseases that can lead to intracranial aneurysms, necessitating advanced diagnostic and treatment options. This demographic shift is prompting healthcare systems to invest more in endovascular procedures and technologies to manage aneurysms effectively, thereby expanding the market for same.

Increased product developmental activities by market players worldwide is also slated to witness market growth for intracranial aneurysms. For example, in June 2022, Medtronic announced the launch of CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms.

Additionally, in September 2023, The Brain Aneurysm Foundation announced the launch of 'Stop the Pop', a new campaign intended to increase awareness of the prevalence and impact of brain aneurysms, and the need for ongoing investment to fund new innovations, screening, and treatment.

Therefore, all the factors stated above collectively will drive the overall intracranial aneurysms market growth.

However, stringent regulatory approval processes, complications associated with intracranial aneurysm treatment devices, and others may prove to be challenging factors for the intracranial aneurysms market growth.

Intracranial Aneurysms Market Segment Analysis:

Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of intracranial aneurysms, the embolization coils category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of embolization coils that enhance their utility and effectiveness.

Embolization coils are critical in the minimally invasive treatment of intracranial aneurysms, offering key features such as high flexibility and visibility under X-ray, which ensure precise placement within the aneurysm. Typically made of platinum, these coils expand to fill the aneurysm sac, inducing clot formation and reducing the risk of rupture. Some coils are coated with bioactive or hydrogel materials to enhance clotting and healing within the aneurysm.

Embolization coils are primarily used for aneurysm occlusion, preventing blood flow into the aneurysm to reduce rupture risk. These are effective for small saccular and wide-necked aneurysms, and in complex cases, they may be used with adjunctive devices like stents or flow diverters to enhance treatment outcomes.

Furthermore, companies raising funds for the development and commercialization of the development of embolic coils are also expected to contribute to the segmental growth of the intracranial aneurysm market. For instance, in July 2021, a neuro- and peripheral-vascular interventional medical device company, Zylox-Tonbridge Medical Technology Co., Ltd. raised USD 329 million to aid the development and commercialization of its core products that include neurovascular embolization coils, a microcatheter for coiling, and others.

Therefore, the widespread uses and various key features of embolization coils that enhance performance and usability are solidifying the impact on the growth of the overall intracranial aneurysms market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall intracranial aneurysms market:

Among all the regions, North America is expected to dominate the intracranial aneurysms market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.

According to recent updated data from the Brain Aneurysm Foundation, stated that currently approximately 6.8 million individuals are affected by the brain aneurysm in the US. Further it added that, about 30,000 people in the US suffers brain aneurysm rupture each year. This condition is more prevalent in the individuals of aged from 35 to 60.

Since the cases of brain aneurysms is rising among middle-aged individuals the demand for more effective diagnostic and treatment options is increasing significantly. This trend is fueling investment in innovative technologies and expanding the market for the intracranial aneurysms.

Rising product developmental activities by market players in the region will further boost the market for intracranial aneurysms. For example, in June 2024, subsidiary of Terumo Corporation (Micro Vention), announced the US launch for its LVIS EVO intraluminal support device. The device is available in the US for the treatment of wide-neck intracranial aneurysms.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional intracranial aneurysms market growth. The presence of key players such as Johnson & Johnson Services, Inc., Medtronic, and Boston Scientific Corporation with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American intracranial aneurysms market.

Intracranial Aneurysms Market key players:

Some of the key market players operating in the intracranial aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc, Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd, Lepu Medical Technology Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd, KANEKA CORPORATION, and others.

Recent Developmental Activities in the Intracranial Aneurysms Market:

  • In June 2024, Softek Illuminate, Inc., provider of enterprise follow-up management and discovery software, announced a new partnership with Wellstar, one of the largest health systems in Georgia, to launch the new Discovery360 Cerebral Aneurysm (CA) program.
  • In June 2024, Medtronic announced the European launch of Artisse, a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the aneurysm.

Key Takeaways from the Intracranial Aneurysms Market Report Study

  • Market size analysis for current intracranial aneurysms market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the intracranial aneurysms market.
  • Various opportunities available for the other competitors in the intracranial aneurysms market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current intracranial aneurysms market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Intracranial Aneurysms Market Report Study

  • Intracranial aneurysms product providers
  • Research organizations and consulting companies
  • Intracranial aneurysms-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in intracranial aneurysms
  • Various end-users who want to know more about the intracranial aneurysms market and the latest technological developments in the intracranial aneurysms market.

Frequently Asked Questions for the Intracranial Aneurysms Market:

1. What are intracranial aneurysms?

  • The intracranial aneurysms or a cerebral aneurysm is an abnormal focal dilation of a brain artery due to the weakening of the inner muscular layer of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning.

2. What is the market for intracranial aneurysms?

  • The intracranial aneurysms market was valued at USD 1.13 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 1.90 billion by 2030.

3. What are the drivers for the intracranial aneurysms market?

  • The intracranial aneurysms market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as hypertension, innovative product developmental activities by leading companies, expanding geriatric population, and increasing government initiatives that are factors expected to escalate the overall growth of the intracranial aneurysms market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the intracranial aneurysms market?

  • Some of the key market players operating in intracranial aneurysms include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc, Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co. Ltd, Lepu Medical Technology Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd, KANEKA CORPORATION, and others.

5. Which region has the highest share in the intracranial aneurysms market?

North America is expected to dominate the overall intracranial aneurysms market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Intracranial Aneurysms Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Intracranial Aneurysms Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Intracranial Aneurysms Market Key Factors Analysis

  • 5.1. Intracranial Aneurysms Market Drivers
    • 5.1.1. Increasing cases of chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Increasing prevalence of lifestyle disorders
    • 5.1.4. Rising geriatric population
  • 5.2. Intracranial Aneurysms Market Restraints and Challenges
    • 5.2.1. The stringent regulatory approval process
    • 5.2.2. Complications associated with intracranial aneurysm treatment devices
  • 5.3. Intracranial Aneurysms Market Opportunities
    • 5.3.1. Research into bioresorbable materials for aneurysm treatment devices
    • 5.3.2. Strategic business activities by the global as well as regional manufacturers

6. Intracranial Aneurysms Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Intracranial Aneurysms Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Surgical Clippings
    • 7.1.2. Embolization Coils
    • 7.1.3. Flow Diverters
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.3. India Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Intracranial Aneurysms Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Intracranial Aneurysms Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Intracranial Aneurysms Market Size in USD million (2021-2030)

8. Intracranial Aneurysms Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. MicroPort Scientific Corporation.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. B. Braun Melsungen AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Johnson & Johnson Services, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Terumo Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Penumbra, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Balt
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Wallaby Medical
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Shape Memory Medical Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Zylox-Tonbridge Medical Technology Co., Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Spartan Micro, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Mizuho Medical Co. Ltd
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Lepu Medical Technology Co., Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Phenox GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Peter LAZIC GmbH
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. adeor medical AG
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Boston Scientific Corporation
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Meril Life Sciences Pvt. Ltd
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. KANEKA CORPORATION
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Intracranial Aneurysms Market in Global (2021-2030)
  • Table 3: Intracranial Aneurysms Market in Global by Product Type (2021-2030)
  • Table 4: Intracranial Aneurysms Market in Global by End-User (2021-2030)
  • Table 5: Intracranial Aneurysms Market in Global by Geography (2021-2030)
  • Table 6: Intracranial Aneurysms Market in North America (2021-2030)
  • Table 7: Intracranial Aneurysms Market in the United States (2021-2030)
  • Table 8: Intracranial Aneurysms Market in Canada (2021-2030)
  • Table 9: Intracranial Aneurysms Market in Mexico (2021-2030)
  • Table 10: Intracranial Aneurysms Market in Europe (2021-2030)
  • Table 11: Intracranial Aneurysms Market in France (2021-2030)
  • Table 12: Intracranial Aneurysms Market in Germany (2021-2030)
  • Table 13: Intracranial Aneurysms Market in United Kingdom (2021-2030)
  • Table 14: Intracranial Aneurysms Market in Italy (2021-2030)
  • Table 15: Intracranial Aneurysms Market in Spain (2021-2030)
  • Table 16: Intracranial Aneurysms Market in the Rest of Europe (2021-2030)
  • Table 17: Intracranial Aneurysms Market in Asia-Pacific (2021-2030)
  • Table 18: Intracranial Aneurysms Market in China (2021-2030)
  • Table 19: Intracranial Aneurysms Market in Japan (2021-2030)
  • Table 20: Intracranial Aneurysms Market in India (2021-2030)
  • Table 21: Intracranial Aneurysms Market in Australia (2021-2030)
  • Table 22: Intracranial Aneurysms Market in South Korea (2021-2030)
  • Table 23: Intracranial Aneurysms Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Intracranial Aneurysms Market in the Rest of the World (2021-2030)
  • Table 25: Intracranial Aneurysms Market in the Middle East (2021-2030)
  • Table 26: Intracranial Aneurysms Market in Africa (2021-2030)
  • Table 27: Intracranial Aneurysms Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Intracranial Aneurysms Market in Global (2021-2030)
  • Figure 3: Intracranial Aneurysms Market in Global by Product Type (2021-2030)
  • Figure 4: Intracranial Aneurysms Market in Global by End-User (2021-2030)
  • Figure 5: Intracranial Aneurysms Market in Global by Geography (2021-2030)
  • Figure 6: Intracranial Aneurysms Market in North America (2021-2030)
  • Figure 7: Intracranial Aneurysms Market in the United States (2021-2030)
  • Figure 8: Intracranial Aneurysms Market in Canada (2021-2030)
  • Figure 9: Intracranial Aneurysms Market in Mexico (2021-2030)
  • Figure 10: Intracranial Aneurysms Market in Europe (2021-2030)
  • Figure 11: Intracranial Aneurysms Market in France (2021-2030)
  • Figure 12: Intracranial Aneurysms Market in Germany (2021-2030)
  • Figure 13: Intracranial Aneurysms Market in United Kingdom (2021-2030)
  • Figure 14: Intracranial Aneurysms Market in Italy (2021-2030)
  • Figure 15: Intracranial Aneurysms Market in Spain (2021-2030)
  • Figure 16: Intracranial Aneurysms Market in the Rest of Europe (2021-2030)
  • Figure 17: Intracranial Aneurysms Market in Asia-Pacific (2021-2030)
  • Figure 18: Intracranial Aneurysms Market in China (2021-2030)
  • Figure 19: Intracranial Aneurysms Market in Japan (2021-2030)
  • Figure 20: Intracranial Aneurysms Market in India (2021-2030)
  • Figure 21: Intracranial Aneurysms Market in Australia (2021-2030)
  • Figure 22: Intracranial Aneurysms Market in South Korea (2021-2030)
  • Figure 23: Intracranial Aneurysms Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Intracranial Aneurysms Market in the Rest of the World (2021-2030)
  • Figure 25: Intracranial Aneurysms Market in the Middle East (2021-2030)
  • Figure 26: Intracranial Aneurysms Market in Africa (2021-2030)
  • Figure 27: Intracranial Aneurysms Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis